Skip to content

Dr. Matijn Weren & Dr. Cindy Malliet

Active
Private limited companyfounded 200917 yrs activeBovenbosstraat 80, 3053 Oud-Heverlee, BelgiumKBO/BCE: BE 0810.654.635

Dr. Matijn Weren & Dr. Cindy Malliet has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €587k and a net result of €97k. Equity remains stable across the filed fiscal years (±1% per year). Its solvency ranks better than 35% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
75 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability74▼-6
Solvency70▼-10
Growth58▼-20
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40k at 30 days acceptable
Liquidity short (current ratio 0.54 against 0.54 in 2024; short-term debt: 43% and cash: 12.2% of total assets), and 55% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
45%
Return on assets
7.5%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 17 years 0 20 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-07-2026, 23 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
23 d early
2024
24 d early
2023
30 d early
2022
25 d early
2021
6 d early
2020
22 d early
2019
21 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€587k▼ 16.1%
2024 · €699k
2018: €593k 2019: €638k 2020: €575k 2021: €650k 2022: €680k 2023: €591k 2024: €699k
2018 → 2025
Total assets
€1.30M▲ 3.4%
2024 · €1.26M
2018: €1.04M 2019: €973k 2020: €951k 2021: €931k 2022: €1.26M 2023: €1.24M 2024: €1.26M
2018 → 2025
Net result
€97k▼ 11.5%
2024 · €110k
2018: €23k 2019: €46k 2020: €45k 2021: €77k 2022: €32k 2023: €113k 2024: €110k
2018 → 2025
Working capital
€-259k▼ 49.4%
2024 · €-173k
2018: €-52k 2019: €-37k 2020: €-84k 2021: €-11k 2022: €-195k 2023: €-277k 2024: €-173k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€650k-€680k▲ 4.6%€591k▼ 13.0%€699k▲ 18.3%€587k▼ 16.1%
Operating result€115k-€56k▼ 51.2%€184k▲ 230%€193k▲ 4.7%€180k▼ 6.8%
Net result€77k-€32k▼ 58.9%€113k▲ 257%€110k▼ 2.9%€97k▼ 11.5%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100k€150k€200kOperating result 2021: €115k€115kNet result 2021: €77k€77kOperating result 2022: €56k€56kNet result 2022: €32k€32kOperating result 2023: €184k€184kNet result 2023: €113k€113kOperating result 2024: €193k€193kNet result 2024: €110k€110kOperating result 2025: €180k€180kNet result 2025: €97k€97k20212022202320242025
The operating result falls in 2025; 2025 is 7% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.30M
Fixed assets €1.00M▼ 5.3%
Current assets €302k▲ 48.7%
Equity and liabilities €1.30M
Equity €587k▼ 16.1%
Debt €718k▲ 27.8%
The debt ratio rises from 44.5% to 55.0%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€237k
2024 · €247k
Cash flow
€154k
2024 · €164k
Solvency
45.0%
2024 · 55.5%
Current ratio
0.54
2024 · 0.54
Quick ratio
0.54
2024 · 0.54
Debt / equity
1.22
2024 · 0.80
ROE
16.6%
2024 · 15.7%
ROA
7.5%
2024 · 8.7%
Interest coverage
5.51
2024 · 6.54
Debt
€718k
2024 · €562k
Debt ≤ 1 year
€561k
2024 · €376k
Debt > 1 year
€157k
2024 · €185k
Income taxes
€40k
2024 · €45k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€1.26M€1.30M
Fixed assets21/28€1.06M€1.00M
Tangible fixed assets22/27€1.06M€1.00M
Land and buildings22€1.04M€984k
Furniture and vehicles24€21k€17k
Financial fixed assets28€1k€2k
Current assets29/58€203k€302k
Amounts receivable within one year40/41€127k€143k
Trade receivables40€127k€123k
Other amounts receivable41-€20k
Current investments50/53€250€250=
Cash at bank and in hand54/58€76k€159k
Equity and liabilities
Total equity and liabilities10/49€1.26M€1.30M
Equity10/15€699k€587k
Contributions10/11€12k€12k=
Reserves13€687k€574k
Distributable reserves133€687k€574k
Profit (loss) carried forward14€0€0=
Amounts payable17/49€562k€718k
Amounts payable after more than one year17€185k€157k
Financial debts170/4€185k€157k
Amounts payable within one year42/48€376k€561k
Current portion of amounts payable after more than one year42€28k€29k
Trade debts44€3k€1k
Suppliers440/4€3k€1k
Taxes, remuneration and social security45€8k€13k
Taxes450/3€8k€13k
Other amounts payable47/48€337k€518k
Income statement Code20242025
Non-recurring operating income76A€2k€0
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€54k€57k
Other operating charges640/8€5k€5k
Gross operating margin9900€252k€242k
Operating profit (loss)9901€193k€180k
Financial income75/76B€8€34
Recurring financial income75€8€34
Financial charges65/66B€38k€43k
Recurring financial charges65€38k€43k
Profit (loss) for the period before taxes9903€155k€137k
Income taxes67/77€45k€40k
Profit (loss) for the period9904€110k€97k
Profit (loss) for the period to be appropriated9905€110k€97k
Appropriation of the result
Profit (loss) to be appropriated9906€110k€97k
Transfer from equity791/2€2k€210k
Transfer to equity691/2€110k€97k
To other reserves6921€110k€97k
Profit to be distributed694/7€2k€210k
Return on contributions (dividend)694€2k€210k

The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
08-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
07-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
01-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Highest result since 2018net €113k ▲257%
Net result €113k, the highest in the series.
06-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
25-07
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
09-07
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
10-07
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
10-07
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2018
19-07
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2017
22-08
NBB filing Annual accounts filed
fiscal year 2016 · micro schema · 22 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Oud-Heverlee · 1 establishment unit since 2009
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Bovenbosstraat 803053 Oud-Heverlee
Ground area
1,728 m²
Building footprint
303 m²
Volume, LiDAR
1,563 m³
Parcel 24034B0023/00K004, Flanders · tallest building 8.0 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Dr. Matijn Weren & Dr. Cindy Malliet
Bovenbosstraat 80, 3053 Oud-HeverleeSpecialist medical practice
since 20092.247.475.449
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24034B0023/00K004 Flanders 1,728 m² 1 · 303 m² 8.0 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 16,628 companies in sector 86220 we hold annual accounts for 7,974. 6,309 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded24-03-2009
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 17 filingsAddress and cadastre registers

Data from official sources, last processed on 23-09-2026. Scores and ratios are computed by Checked and are not a credit decision.